NPM1 Minimal Residual Disease Detection at Any Time by Clinical Next Generation Sequencing Predicts Poor Survival in Acute Myeloid Leukemia

被引：0
|
作者：
Sallman, D. [1 ]
Xie, Z. [1 ]
Chan, O. [1 ]
Shao, R. [2 ]
Song, J. [2 ]
Hussaini, M. O. [2 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol, Tampa, FL USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Pathol & Lab Med, Tampa, FL USA
来源：
AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 2024年 / 162卷
关键词：
D O I：
10.1093/ajcp/aqae129.182
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
aqae129.18
引用
收藏
页码：S83 / S83
页数：1
相关论文
共 50 条
  • [41] Acute myeloid leukemia with mutated nucleophosmin (NPM1): Any hope for a targeted therapy?
    Falini, Brunangelo
    Gionfriddo, Ilaria
    Cecchetti, Federica
    Ballanti, Stelvio
    Pettirossi, Valentina
    Martelli, Maria Paola
    BLOOD REVIEWS, 2011, 25 (06) : 247 - 254
  • [42] High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival
    van Rhenen, A
    Feller, N
    Kelder, A
    Westra, AH
    Rombouts, E
    Zweegman, S
    van der Pol, MA
    Waisfisz, Q
    Ossenkoppele, GJ
    Schuurhuis, GJ
    CLINICAL CANCER RESEARCH, 2005, 11 (18) : 6520 - 6527
  • [43] Molecular Detection of Minimal Residual Disease before Allogeneic Stem Cell Transplantation Predicts a High Incidence of Early Relapse in Adult Patients with NPM1 Positive Acute Myeloid Leukemia
    Lussana, Federico
    Caprioli, Chiara
    Stefanoni, Paola
    Pavoni, Chiara
    Spinelli, Orietta
    Buklijas, Ksenija
    Michelato, Anna
    Borleri, GianMaria
    Algarotti, Alessandra
    Mico, Caterina
    Grassi, Anna
    Intermesoli, Tamara
    Rambaldi, Alessandro
    CANCERS, 2019, 11 (10)
  • [44] Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations
    Chou, W-C
    Tang, J-L
    Wu, S-J
    Tsay, W.
    Yao, M.
    Huang, S-Y
    Huang, K-C
    Chen, C-Y
    Huang, C-F
    Tien, H-F
    LEUKEMIA, 2007, 21 (05) : 998 - 1004
  • [45] Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations
    W-C Chou
    J-L Tang
    S-J Wu
    W Tsay
    M Yao
    S-Y Huang
    K-C Huang
    C-Y Chen
    C-F Huang
    H-F Tien
    Leukemia, 2007, 21 : 998 - 1004
  • [46] Postinduction Minimal Residual Disease Predicts Outcome and Benefit From Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia With NPM1 Mutation: A Study by the Acute Leukemia French Association Group
    Balsat, Marie
    Renneville, Aline
    Thomas, Xavier
    de Botton, Stephane
    Caillot, Denis
    Marceau, Alice
    Lemasle, Emilie
    Marolleau, Jean-Pierre
    Nibourel, Olivier
    Berthon, Celine
    Raffoux, Emmanuel
    Pigneux, Arnaud
    Rodriguez, Celine
    Vey, Norbert
    Cayuela, Jean-Michel
    Hayette, Sandrine
    Braun, Thorsten
    Coude, Marie Magdeleine
    Terre, Christine
    Celli-Lebras, Karine
    Dombret, Herve
    Preudhomme, Claude
    Boissel, Nicolas
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (02) : 185 - +
  • [47] DETECTION NPM1 MUTATION AND CLINICAL CHARACTERS IN ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA IN THE MONGOLIA
    Oyunbileg, S.
    Davaabayar, B.
    Oyunderlger, N.
    Sevjidmaa, B.
    HUMAN GENE THERAPY, 2018, 29 (11) : A13 - A13
  • [48] Patient-tailored analysis of minimal residual disease in acute myeloid leukemia using next-generation sequencing
    Malmberg, Erik B. R.
    Stahlman, Sara
    Rehammar, Anna
    Samuelsson, Tore
    Alm, Sofie J.
    Kristiansson, Erik
    Abrahamsson, Jonas
    Garelius, Hege
    Pettersson, Louise
    Ehinger, Mats
    Palmqvist, Lars
    Fogelstrand, Linda
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2017, 98 (01) : 26 - 37
  • [49] Molecular measurable residual disease monitoring and transplant indications in NPM1 mutated acute myeloid leukemia
    Christopher, Mary R.
    Nawas, Mariam T.
    Reagan, John L.
    BONE MARROW TRANSPLANTATION, 2025, 60 (02) : 135 - 143
  • [50] Molecular Minimal Residual Disease After Induction Is Related to ABC Proteins' Activity and Associated with Survival in 26 Patients with NPM1 Mutated Acute Myeloid Leukemia
    Hirsch, Pierre
    Tang, Ruoping
    Marzac, Christophe
    Fava, Fanny
    Perrot, Jean-Yves
    Isnard, Francoise
    Marie, Jean-Pierre
    Legrand, Ollivier
    BLOOD, 2012, 120 (21)
12345